MATHIAS OELKE

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ John Rudy, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MATHIAS OELKE:

Company Role Class Num Shares Value Price $ Report Date Ownership
NexImmune, Inc. Chief Science Officer Common Stock 134,023 $54,990 $0.4103 22 Nov 2022 Direct
NexImmune, Inc. Chief Science Officer Stock Option (right to buy) 15,793 04 Apr 2023 Direct

Insider Reports Filed by MATHIAS OELKE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123023687-oelke-mathias-2023-04-04 NexImmune, Inc. 04 Apr 2023 17 $0 4 Chief Science Officer 06 Apr 2023, 20:41
/report/000120919122058800-oelke-mathias-2022-11-22 NexImmune, Inc. 22 Nov 2022 1 $0 4 Chief Science Officer 25 Nov 2022, 16:04
/report/000120919122023749-oelke-mathias-2022-04-05 NexImmune, Inc. 05 Apr 2022 1 $0 4 Chief Science Officer 07 Apr 2022, 19:24
/report/000120919122023744-oelke-mathias-2022-04-05 NexImmune, Inc. 05 Apr 2022 0 $0 3 Chief Science Officer 07 Apr 2022, 19:10